CARYSIL Intrinsic Value
CARYSIL (CARYSIL) median intrinsic value is ₹1021.23 from 9 valuation models (range ₹335–₹2533), vs current price ₹1116.50 — -8.5% downside (Trading Near Calculated Value), margin of safety -9.3%. Read CARYSIL dividend payments for the complete payout history and dividend yield track record.
CARYSIL Valuation Methods Summary — DCF, Graham Number & P/E
CARYSIL intrinsic value across 9 models vs current price ₹1116.50 — upside/downside and value range per method. Analyse CARYSIL shareholder distribution to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹952.00 | ₹761.60 - ₹1142.40 | -14.7% | EPS: ₹38.08, Sector P/E: 25x |
| Book Value Method | asset | ₹2533.33 | ₹2280.00 - ₹2786.66 | +126.9% | Book Value/Share: ₹1013.33, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹2233.00 | ₹2009.70 - ₹2456.30 | +100.0% | Revenue/Share: ₹1586.67, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹2233.00 | ₹2009.70 - ₹2456.30 | +100.0% | EBITDA: ₹200.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹1021.23 | ₹816.98 - ₹1225.48 | -8.5% | CF Growth: 7.5%, Discount: 15% |
| PEG Ratio Method | growth | ₹334.95 | ₹301.45 - ₹368.44 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹706.00 | ₹635.40 - ₹776.60 | -36.8% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| ROE Based Valuation | profitability | ₹2233.00 | ₹2009.70 - ₹2456.30 | +100.0% | ROE: 17.8%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹931.79 | ₹838.61 - ₹1024.97 | -16.5% | EPS: ₹38.08, BVPS: ₹1013.33 |
CARYSIL Intrinsic Value vs Market Price — All Valuation Models
CARYSIL fair value range ₹335–₹2533 vs current market price ₹1116.50 across 9 valuation models. For current market price and key ratios, visit CARYSIL share price chart.
CARYSIL Intrinsic Value Analysis — Undervalued or Overvalued?
CARYSIL median intrinsic value ₹1021.23, current price ₹1116.50 — Trading Near Calculated Value by 8.5%, margin of safety -9.3%.
What is the intrinsic value of CARYSIL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of CARYSIL (CARYSIL) is ₹1021.23 (median value). With the current market price of ₹1116.50, this represents a -8.5% variance from our estimated fair value.
The valuation range spans from ₹334.95 to ₹2533.33, indicating ₹334.95 - ₹2533.33.
Is CARYSIL undervalued or overvalued?
Based on our multi-method analysis, CARYSIL (CARYSIL) appears to be trading near calculated value by approximately 8.5%.
CARYSIL Financial Health — Key Ratios vs Industry Benchmarks
CARYSIL financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.89 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 17.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 19.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.91x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
CARYSIL Cash Flow Quality — Operating & Free Cash Flow
CARYSIL operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹60 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹53 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹71 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹52 Cr | ₹16 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹45 Cr | ₹28 Cr | Positive Free Cash Flow | 8/10 |